(Q37773294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

review article

1 reference

title

Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

Anton B Alexandroff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Steve Nicholson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Poulam M Patel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

551-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

BCG immunotherapy of bladder cancer: 20 years on.

7 February 2020

cites work

1 reference

Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

21 January 2018

1 reference

Bladder cancer: narrowing the gap between evidence and practice

21 January 2018

1 reference

Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses

21 January 2018

1 reference

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer

21 January 2018

1 reference

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

21 January 2018

1 reference

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder

21 January 2018

1 reference

Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder

21 January 2018

1 reference

Mechanisms of action of intravesical bacille Calmette-Guérin: local immune mechanisms.

21 January 2018

1 reference

Bacille-Calmette Guèrin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1.

21 January 2018

1 reference

A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

21 January 2018

1 reference

Interaction of dendritic cells with mycobacteria: where the action starts

21 January 2018

1 reference

Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells

21 January 2018

1 reference

Role of neutrophils in BCG immunotherapy for bladder cancer

21 January 2018

1 reference

Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.

21 January 2018

1 reference

The role of granulocytes following intravesical BCG prophylaxis.

21 January 2018

1 reference

Role for CD40-CD40 ligand interactions in the immune response to solid tumours

21 January 2018

1 reference

Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.

21 January 2018

1 reference

Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

21 January 2018

1 reference

CD40 expression in bladder cancer

21 January 2018

1 reference

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

Protumor vs antitumor functions of IL-17.

21 January 2018

1 reference

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited

21 January 2018

1 reference

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12

21 January 2018

1 reference

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.

21 January 2018

1 reference

Development and function of TH17 cells in health and disease

21 January 2018

1 reference

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines

21 January 2018

1 reference

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).

21 January 2018

1 reference

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

FOXP3+ regulatory T cells: Current controversies and future perspectives

21 January 2018

1 reference

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

21 January 2018

1 reference

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

21 January 2018

1 reference

IL-23 and IL-17 in tuberculosis

21 January 2018

1 reference

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t.

21 January 2018

1 reference

Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

21 January 2018

1 reference

Purification and characterisation of soluble intercellular adhesion molecule-1 and its effect on cell-mediated cytolysis of bladder tumour cells.

21 January 2018

1 reference

Report from the 67th annual meeting of the American Academy of Dermatology

21 January 2018

1 reference

Rapid identification of mycobacteria by Raman spectroscopy

21 January 2018

1 reference

Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling

21 January 2018

1 reference

Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy.

21 January 2018

1 reference

Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.

21 January 2018

1 reference

Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy.

21 January 2018

1 reference

Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003231

Identifiers

DOI

10.2217/IMT.10.32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20636008%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference